Sympathetic Overactivity in Uremia

Journal of Renal Nutrition

Volumn 18, Issue 1, 2008, Pages 118-121

  Ksiazek, Andrzej ^a   Załuska, Wojciech ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II; NORADRENALIN;

ADRENERGIC SYSTEM; ARTICLE; BLOOD; CHRONIC KIDNEY FAILURE; PATHOLOGY; PATHOPHYSIOLOGY; UREMIA;

ANGIOTENSIN II; KIDNEY FAILURE, CHRONIC; NOREPINEPHRINE; SYMPATHETIC NERVOUS SYSTEM; UREMIA;

EID: 37049034231     PISSN: 10512276     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jrn.2007.10.024     Document Type: Article

References (21)

1. Ksia{ogonek}żek A. Dopamine-beta-hydroxylase activity and catecholamine levels in the plasma of patients with renal failure. Nephron 24 (1979) 170-173
2. Campese V.M., Romoff M.S., Levitan D., Lane K., and Massry S.G. Mechanisms of autonomic nervous system dysfunction in uremia. Kidney Int 20 (1981) 246-253
3. Kotanko P. Cause and consequences of sympathetic hyperactivity in chronic kidney disease. Blood Purif 24 (2006) 95-99
4. Hausberg M., Kosch M., Harmelink P., et al. Sympathetic nerve activity in end-stage renal disease. Circulation 106 (2002) 1974-1979
5. Ksia{ogonek}żek P., Buraczyńska K., and Buraczynska M. Norepinephrine transporter gene (NET) polymorphism in patients with type 2 diabetes. Kidney Blood Press Res 29 (2006) 338-343
6. Vallbo A.B., Hagbarth K.E., Torebjork H.E., and Wallin B.G. Somatosensory, proprioceptive, and sympathetic activity in human peripheral nerves. Physiol Rev 59 (1979) 919-957
7. Campese V.M., Kogosov E., and Koss M. Renal afferent denervation prevents the progression of renal disease in the renal ablation model of chronic renal failure in the rat. Am J Kidney Dis 26 (1995) 861-865
8. Campese V.M., and Kogosov E. Renal afferent denervation prevents hypertension in rats with chronic renal failure. Hypertension 25 (1995) 878-882
9. Converse Jr. R.L., Jacobsen T.N., Toto R.D., et al. Sympathetic overactivity in patients with chronic renal failure. N Engl J Med 327 (1992) 1912-1918
10. Mallamaci F., Tripepi G., Maas R., Malatino L., Boger R., and Zoccali C. Analysis of the relationship between norepinephrine and asymmetric dimethyl arginine levels among patients with end-stage renal disease. J Am Soc Nephrol 15 (2004) 435-441
11. Augustyniak R.A., Tuncela M., Zhanga W., Totob R.D., and Victora R.G. Sympathetic overactivity as a cause of hypertension in chronic renal failure. J Hypertens 20 (2002) 3-9
12. Denton K.M., Shweta A., and Anderson W.P. Preglomerular and postglomerular resistance responses to different levels of sympathetic activation by hypoxia. J Am Soc Nephrol 13 (2002) 27-34
13. Koomans H.A., Blankestijn P.J., and Joles J.A. Sympathetic hyperactivity in chronic renal failure: a wake-up call. J Am Soc Nephrol 15 (2004) 524-537
14. Kotanko P., Binder A., Tasker J., et al. Essential hypertension in African Caribbeans associates with a variant of the beta2-adrenoceptor. Hypertension 30 (1997) 773-776
15. Phillips J.K. Pathogenesis of hypertension in renal failure: role of the sympathetic nervous system and renal afferents. Clin Exp Pharmacol Physiol 32 (2005) 415-418
16. Ravera M., Re M., Deferrari L., Vettorreti S., and Deferrari G. Importance of blood pressure control in chronic kidney disease. J Am Soc Nephrol 17 (2006) 98-103
17. Zoccali C, Mallamaci F, Parlongo S, et al: Plasma norepinephrine predicts survival and incident cardiovascular events in patients with end-stage renal disease Circulation 105:1354-1359, 2002
18. Neumann J., Ligtenberg G., Klein II, Koomans H.A., and Blankestijn P.J. Moxonidine normalizes sympathetic hyperactivity in patients with eprosartan-treated chronic renal failure. J Am Soc Nephrol 15 (2004) 2902-2907
19. Frank H., Heusser K., Höffken B., Huber P., Schmieder R.E., and Schobel H.P. Effect of erythropoietin on cardiovascular prognosis parameters in hemodialysis patients. Kidney Int 66 (2004) 832-840
20. Hallwell J.R., and Minson C.T. Effect of hypoxia on arterial baroreflex control of heart rate and muscle sympathetic nerve activity in humans. J Appl Physiol 93 (2002) 857-864
21. Ksia{ogonek}żek A., Załuska W., and Ksia{ogonek}żek P. Effect of recombinant human erythropoietin on adrenergic activity in normotensive hemodialysis patients. Clin Nephrol 56 (2001) 104-110